Production (Stage)
Drugs Made In America Acquisition Corp.
DMAA
$10.18
-$0.01-0.10%
NASDAQ
| 03/31/2025 | 12/31/2024 | 06/30/2024 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 900.00 | 1.40K | 18.10K | ||
| Total Receivables | -- | -- | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 70.10K | 3.60K | 60.00K | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | -- | -- | ||
| Total Current Assets | 71.00K | 5.00K | 78.10K | ||
|
|
|||||
| Total Current Assets | 71.00K | 5.00K | 78.10K | ||
| Net Property, Plant & Equipment | -- | -- | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 232.74M | 545.80K | 113.00K | ||
| Total Assets | 232.81M | 550.80K | 191.10K | ||
|
|
|||||
| Total Accounts Payable | -- | -- | -- | ||
| Total Accrued Expenses | 132.50K | 77.30K | -- | ||
| Short-term Debt | 60.90K | 662.30K | 210.10K | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | -- | -- | -- | ||
| Total Finance Division Other Current Liabilities | 154.00K | 56.10K | 900.00 | ||
| Total Other Current Liabilities | 154.00K | 56.10K | 900.00 | ||
| Total Current Liabilities | 347.40K | 795.70K | 211.00K | ||
|
|
|||||
| Total Current Liabilities | 347.40K | 795.70K | 211.00K | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | 60.90K | 662.30K | 210.10K | ||
| Capital Leases | -- | -- | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | 239.64M | -- | -- | ||
| Total Liabilities | 239.98M | 795.70K | 211.00K | ||
|
|
|||||
| Common Stock & APIC | 1.10K | 35.00K | 35.00K | ||
| Retained Earnings | -6.33M | -279.80K | -54.90K | ||
| Treasury Stock & Other | -852.40K | -- | -- | ||
| Total Common Equity | -7.18M | -244.80K | -19.90K | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | -- | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
|
|
|||||
| Total Common Equity | -7.18M | -244.80K | -19.90K | ||
| Total Preferred Equity | -- | -- | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | -7.18M | -244.80K | -19.90K | ||
|
|
|||||